News Announcement

Bliss GVS Pharma: Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday August 12 2026

We wish to inform you that the Board Meeting of the Company was held today i.e. on Wednesday August 12 2026 through Video Conferencing ("VC")/Other Audio-Visual Means ("OAVM") with the deemed venue being the Registered Office of the Company. Pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board has considered and approved the following matter amongst others:1.The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2026. A copy of the unaudited standalone and consolidated financial results along with the Limited Review Report of the Auditors are enclosed below.2.The draft of the Postal Ballot Notice seeking the approval of members of the Company for the appointment of Mr. Santosh Parab (DIN: 01622988) as a Director of the Company in the capacity of Non-Executive Non-Independent Director of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.